Related Experiment Video
Updated: Jun 16, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Management of Systemic Cardiotoxicity Associated with Antidepressant Use in Patients with Depressive Disorders: A
Omar Anwar Saleh Al Nakhebi1, Raluka Albu-Kalinovic1, Adela Bosun1
1Doctoral School, University of Medicine and Pharmacy Victor Babes Timisoara, 300041 Timisoara, Romania.
Insights
Antidepressant use is linked to cardiotoxicity, a serious adverse effect. A multidisciplinary approach is crucial for managing and protecting patients from these cardiac risks.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Depression significantly impacts global health and quality of life.
- Antidepressants are vital for depression treatment but carry risks, including cardiotoxicity.
- Understanding antidepressant-induced cardiotoxicity is critical for patient safety.
Purpose of the Study:
- To systematically review and analyze the correlation between antidepressant use and cardiotoxicity.
- To evaluate the importance of a multidisciplinary approach in managing patients at risk.
- To inform clinical practice regarding antidepressant-induced cardiac adverse effects.
Main Methods:
- Systematic literature search adhering to PRISMA guidelines.
- Inclusion of twenty studies for quantitative analysis.
- Risk of bias assessment using the Joanna Briggs Institute critical appraisal tool.
Main Results:
- A significant correlation was identified between antidepressant intake and cardiotoxicity.
- The necessity of a multidisciplinary strategy for patient protection was highlighted.
- Pathophysiological mechanisms and therapeutic options were explored.
Conclusions:
- Effective management of antidepressant-induced cardiotoxicity necessitates understanding its mechanisms.
- Critical evaluation of therapeutic strategies is essential for clinical practice.
- A comprehensive approach is vital for mitigating cardiac risks associated with antidepressants.
Abstract:
Background: Depression is one of the leading causes of disability worldwide, with a significant impact on individuals' quality of life. The use of antidepressants is fundamental in the treatment of this condition; however, it is essential to recognize that the use of these drugs can be associated with adverse effects, including cardiotoxicity. Methods: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a literature search was conducted of the PubMed/Medline, Scopus, and Cochrane databases. Twenty studies were included in the final quantitative analysis. The Joanna Briggs Institute critical appraisal tool was used to assess the risk of bias. Results: It is possible to highlight a correlation between intake of antidepressants and development of cardiotoxicity. Analysis of the selected studies allows for an understanding of the importance of a multidisciplinary approach for the protection of these patients. Conclusions: Management of antidepressant-induced cardiotoxicity requires a thorough understanding of the pathophysiological mechanisms involved and a critical evaluation of the various therapeutic strategies available to promote clinical practice.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Therapy
Antianxiety Medications
Mania and Antimanic Drugs: Overview

